Your fact-checks will appear here
Treatment options for scabies, including ivermectin and topical scabicides
Ivermectin dosing for human parasitic infections is weight-based, most commonly prescribed at about 200 micrograms per kilogram (mcg/kg) as a single oral dose for strongyloidiasis and many scabies reg...
Ivermectin dosing in humans is disease-specific and weight‑based: standard microgram-per-kilogram regimens range from about 150–200 µg/kg for onchocerciasis, strongyloidiasis and enterobiasis, to 400 ...
Ivermectin dosing is weight‑based, typically calculated in micrograms per kilogram and most often given as a single oral dose; common regimens for human parasitic infections fall between about 150 and...
Ivermectin dosing for human parasitic infections is weight-based and generally expressed in micrograms per kilogram (mcg/kg); the usual therapeutic range for common infections is about 150–200 mcg/kg ...
Crusted (Norwegian) scabies is managed with oral ivermectin at a standard per‑dose of 200 micrograms (µg) per kilogram, but immunocompromised patients typically require multiple, repeated doses rather...
Mass drug administration (MDA) campaigns generally follow product labels and operational guidelines that instruct taking oral ivermectin on an empty stomach, but real-world practice balances that dire...
Oral ivermectin is the standard human route and produces moderate systemic bioavailability that is sensitive to formulation and food (notably high-fat meals) and to intestinal metabolism and efflux me...
The standard, weight‑based oral ivermectin dose used for adult parasitic infections is generally between 150 and 200 micrograms per kilogram (0.15–0.20 mg/kg), most commonly cited as 200 mcg/kg for si...
Ivermectin dosing for human parasitic infections is weight‑based and typically ranges from about 150 to 400 micrograms per kilogram (mcg/kg) depending on the pathogen, the clinical scenario, and publi...
Ivermectin is a proven antiparasitic drug in humans for specific infections such as onchocerciasis and scabies, but there is no convincing clinical evidence that it cures or prevents cancer in humans;...
A high‑fat meal can increase systemic exposure to oral ivermectin by improving solubilization and absorption of this lipophilic drug, but the magnitude of that effect is inconsistent across studies an...
Prescription topical ivermectin (Soolantra, 1% w/w) is a dermatologic cream formulated and tested for human use with clinical trial safety data and labeling guidance; it is not the same as veterinary ...
Clinical research has tested ivermectin beyond its core approvals (onchocerciasis, strongyloidiasis, and topical formulations for rosacea/head lice) in a range of parasitic contexts — notably scabies,...
Ivermectin in adults is associated with a spectrum of recognized adverse reactions that can be neurological (confusion, seizures, encephalopathy) and allergic or cutaneous (rash, pruritus, severe hype...
Ivermectin is a potent antiparasitic that is effective against many nematodes (roundworms) and some ectoparasites in humans—most notably strongyloidiasis, onchocerciasis (microfilariae), scabies and l...
Ivermectin residues vary markedly with formulation, route, and species: injectable and long‑acting preparations produce the highest and most persistent tissue and milk residues requiring weeks to mont...
Ivermectin’s standard, evidence-backed human dosing for parasitic infections is generally in the 150–200 micrograms per kilogram (mcg/kg) single-dose range, with some indications and expert guides ext...